Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.

Benzer Materyaller

• Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397).
  Yazar:: Buettner, F, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial.
  Yazar:: Buettner, F, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.
  Yazar:: Gulliford, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
  Yazar:: Gulliford, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848]
  Yazar:: Bulpitt CJ, ve diğerleri
  Baskı/Yayın Bilgisi: (2002-10-01)